SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-091762
Filing Date
2022-03-31
Accepted
2022-03-31 16:08:15
Documents
18
Period of Report
2022-03-29
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d340920d8k.htm   iXBRL 8-K 30298
2 EX-1.1 d340920dex11.htm EX-1.1 267548
3 EX-4.1 d340920dex41.htm EX-4.1 91902
4 EX-4.2 d340920dex42.htm EX-4.2 96736
5 EX-4.3 d340920dex43.htm EX-4.3 98958
6 EX-5.1 d340920dex51.htm EX-5.1 13303
10 GRAPHIC g340920dsp164.jpg GRAPHIC 3794
  Complete submission text file 0001193125-22-091762.txt   882049

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA cala-20220329.xsd EX-101.SCH 2864
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE cala-20220329_lab.xml EX-101.LAB 17996
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cala-20220329_pre.xml EX-101.PRE 11267
12 EXTRACTED XBRL INSTANCE DOCUMENT d340920d8k_htm.xml XML 3361
Mailing Address 343 OYSTER POINT BLVD #200 SOUTH SAN FRANCISCO CA 94080
Business Address 343 OYSTER POINT BLVD #200 SOUTH SAN FRANCISCO CA 94080 650-870-1000
Calithera Biosciences, Inc. (Filer) CIK: 0001496671 (see all company filings)

IRS No.: 272366329 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36644 | Film No.: 22792500
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences